The National Cancer Institute is offering a grant to integrate cognitive neuroscience approaches in assessing acute and chronic cognitive changes post cancer treatment for non-CNS malignancies. Applicants are encouraged to improve traditional assessment methods, promoting better understanding and management of treatment-related cognitive impairment. Closing date for submission is on June 8, 2022, at 12:00 AM EDT.
Opportunity ID: 319411
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-19-340 |
Funding Opportunity Title: | Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.395 — Cancer Treatment Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 12, 2019 |
Last Updated Date: | Aug 12, 2019 |
Original Closing Date for Applications: | Jun 08, 2022 |
Current Closing Date for Applications: | Jun 08, 2022 |
Archive Date: | Jul 14, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) State governments Special district governments Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public housing authorities/Indian housing authorities City or township governments County governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-340.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 319411 Full Announcement-PAR-19-340 -> PAR-19-340-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00253802 | Sep 09, 2019 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259096 | Sep 09, 2019 | Jan 24, 2022 | View | |
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269703 | Oct 28, 2021 | Jun 08, 2022 | View |
Package 1
Mandatory forms
319411 RR_SF424_2_0-2.0.pdf
319411 PHS398_CoverPageSupplement_4_0-4.0.pdf
319411 RR_OtherProjectInfo_1_4-1.4.pdf
319411 PerformanceSite_2_0-2.0.pdf
319411 RR_KeyPersonExpanded_2_0-2.0.pdf
319411 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
319411 RR_Budget_1_4-1.4.pdf
319411 RR_SubawardBudget30_1_4-1.4.pdf
319411 PHS398_ModularBudget_1_2-1.2.pdf
319411 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
319411 RR_SF424_2_0-2.0.pdf
319411 PHS398_CoverPageSupplement_5_0-5.0.pdf
319411 RR_OtherProjectInfo_1_4-1.4.pdf
319411 PerformanceSite_2_0-2.0.pdf
319411 RR_KeyPersonExpanded_2_0-2.0.pdf
319411 PHS398_ResearchPlan_4_0-4.0.pdf
319411 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
319411 RR_Budget_1_4-1.4.pdf
319411 RR_SubawardBudget30_1_4-1.4.pdf
319411 PHS398_ModularBudget_1_2-1.2.pdf
319411 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
319411 RR_SF424_5_0-5.0.pdf
319411 PHS398_CoverPageSupplement_5_0-5.0.pdf
319411 RR_OtherProjectInfo_1_4-1.4.pdf
319411 PerformanceSite_4_0-4.0.pdf
319411 RR_KeyPersonExpanded_4_0-4.0.pdf
319411 PHS398_ResearchPlan_4_0-4.0.pdf
319411 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
319411 RR_Budget_3_0-3.0.pdf
319411 RR_SubawardBudget30_3_0-3.0.pdf
319411 PHS398_ModularBudget_1_2-1.2.pdf
319411 PHS_AssignmentRequestForm_3_0-3.0.pdf